2015 Quality Performance Results

Measure number

Measure Name

2015 reporting period

ACO performance rate

Mean performance rate (SSP - ACOs)

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

79.76

80.61

ACO-2

CAHPS: How Well Your Providers Communicate

93.10

92.65

ACO-3

CAHPS: Patients’ Rating of Provider

92.13

91.94

ACO-4

CAHPS: Access to Specialists

87.60

83.61

ACO-5

CAHPS: Health Promotion and Education

65.30

59.06

ACO-6

CAHPS: Shared Decision Making

76.80

75.17

ACO-7

CAHPS: Health Status/Functional Status

74.97

72.30

ACO-34

CAHPS: Stewardship of Patient Resources*

22.31

26.87

ACO-8

Risk Standardized, All Condition Readmission

15.27

14.86

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* Readmission

17.68

18.07

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes*

62.81

54.60

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure*

88.05

76.96

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

74.69

62.92

ACO-9

Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

1.30

1.11

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)

1.73

1.04

ACO-11

Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements

76.47

80.14

ACO-39

Documentation of Current Medications in the Medical Record*

96.00

84.07

ACO-13

Falls: Screening for Future Fall Risk

75.40

56.46

ACO-14

Preventive Care and Screening: Influenza Immunization

70.87

62.03

ACO-15

Pneumonia Vaccination Status for Older Adults

74.61

63.73

ACO-16

6 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up

85.10

71.15

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

97.28

90.16

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

64.34

45.25

ACO-19

Colorectal Cancer Screening

66.02

60.06

ACO-20

Breast Cancer Screening

81.78

65.67

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

86.68

70.04

ACO-40

Depression Remission at Twelve Months*

N/A

N/A

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

12.55

20.38

ACO-41

Diabetes: Eye Exam*

54.24

41.05

ACO-28

Hypertension: Controlling High Blood Pressure

81.52

69.62

ACO-30

Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic

90.15

83.82

ACO-31

Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

96.10

87.22

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

96.06

77.73

CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease. *= Measure required beginning Reporting Year 2015. N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A

For more information on how to interpret scores on the above quality performance measures, see https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/MSSP-QM-Benchmarks.pdf